Ankur Pandya (A Pandya)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Venues

Journal of the American Heart Association

American journal of hematology

Blood

AJNR. American journal of neuroradiology

Harvard T.H. Chan School of Public Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard T.H. Chan School of Public Health Oct 01 2014

United States

Associate Professor of Health Decision Science :: Health Policy and Management

Publications

Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Paul M Wechsler, Ankur Pandya, Neal S Parikh, Junaid Abdul Razzak, Halina White, Babak Benjamin Navi, Hooman Kamel, Ava L Liberman
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor Stroke. Journal of the American Heart Association 13 (7) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Paul M Wechsler, Ankur Pandya, Neal S Parikh, Junaid Abdul Razzak, Halina White, Babak Benjamin Navi, Hooman Kamel, Ava L Liberman
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor Stroke. Journal of the American Heart Association 13 (7) (2024)
Paul M Wechsler, Ankur Pandya, Neal S Parikh, Junaid Abdul Razzak, Halina White, Babak Benjamin Navi, Hooman Kamel, Ava L Liberman
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor Stroke. Journal of the American Heart Association (2024)
David Glynn, John C Giardina, Julia Hatamyar, Ankur Pandya, Marta O Soares, Noemi Kreif
Integrating decision modeling and machine learning to inform treatment stratification. Health economics (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
David Glynn, John C Giardina, Julia Hatamyar, Ankur Pandya, Marta O Soares, Noemi Kreif
Integrating decision modeling and machine learning to inform treatment stratification. Health economics 33 (8) (2024)
Paul M Wechsler, Ankur Pandya, Neal S Parikh, Junaid Abdul Razzak, Halina White, Babak Benjamin Navi, Hooman Kamel, Ava L Liberman
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor Stroke. Journal of the American Heart Association 13 (7) (2024)
Paul M Wechsler, Ankur Pandya, Neal S Parikh, Junaid Abdul Razzak, Halina White, Babak Benjamin Navi, Hooman Kamel, Ava L Liberman
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor Stroke. Journal of the American Heart Association 13 (7) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology (2024)
Pamela P Pei, Kieran P Fitzmaurice, Mylinh H Le, Christopher Panella, Michelle L Jones, Ankur Pandya, C Robert Horsburgh, Kenneth A Freedberg, Milton C Weinstein, A David Paltiel, Krishna P Reddy
The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis. MDM policy & practice 8 (2) (2023)
Andrea Luviano, Ankur Pandya
Evolution of Value in American College of Cardiology/American Heart Association Clinical Practice Guidelines. Circulation. Cardiovascular quality and outcomes (2023)
Brandon W Yan, Aferdita Spahillari, Ankur Pandya
Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States. Circulation. Cardiovascular quality and outcomes (2023)
Yin Ge, Ankur Pandya, Sarah A M Cuddy, Amitoj Singh, Avinainder Singh, Sharmila Dorbala
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis. Journal of the American Heart Association 11 (18) (2022)
Edward Robert Scheffer Cliff, Ankur Pandya
Pola-R-CHP for DLBCL: cost-effective at first glance. Blood 140 (25) (2022)
A T Boltyenkov, Jason J Wang, Joseph Schindler, Jeffrey M Katz, Amir R Dehdashti, Timothy G White, Gabriela Martinez, Ankur Pandya, Pina C Sanelli
Optimizing Small, Low-Risk, Unruptured Intracranial Aneurysm Treatment Using Game Theory. AJNR. American journal of neuroradiology 43 (2) (2022)
Edward Robert Scheffer Cliff, Ankur Pandya
Pola-R-CHP for DLBCL: cost-effective at first glance. Blood 140 (25) (2022)
Edward Robert Scheffer Cliff, Ankur Pandya
Pola-R-CHP for DLBCL: cost-effective at first glance. Blood 140 (25) (2022)
Ankur Pandya, Mike Paulden, Jinyi Zhu, Tara A Lavelle, James Hammitt
Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates. Medical decision making : an international journal of the Society for Medical Decision Making 42 (7) (2022)
Edward Robert Scheffer Cliff, Ankur Pandya
Pola-R-CHP for DLBCL: cost-effective at first glance. Blood 140 (25) (2022)
Edward Robert Scheffer Cliff, Ankur Pandya
Pola-R-CHP for DLBCL: cost-effective at first glance. Blood 140 (25) (2022)
Jinyi Zhu, Ankur Pandya
The Advantages and Nuances of Using Disability-Adjusted Life Years to Characterize Cardiovascular Disease Burden: Insights From Parents and Offspring. Circulation. Cardiovascular quality and outcomes (2022)
Jeffrey M Katz, Jason J Wang, A T Boltyenkov, Gabriela Martinez, J O'Hara, C Feizullayeva, Michele Gribko, Ankur Pandya, Pina C Sanelli
Rescan Time Delays in Ischemic Stroke Imaging: A Retrospective Observation and Analysis of Causes and Clinical Impact. AJNR. American journal of neuroradiology 42 (10) (2021)
Jana Ivanidze, Resmi A Charalel, Igor Shuryak, David J Brenner, Ankur Pandya, Omar N Kallas, K Kesavabhotla, Alan Z Segal, M S Simon, Pina C Sanelli
Effects of Radiation Exposure on the Cost-Effectiveness of CT Angiography and Perfusion Imaging in Aneurysmal Subarachnoid Hemorrhage. AJNR. American journal of neuroradiology 38 (3) (2017)

Ankur Pandya.css-eqlu8i{font-size:small;padding-left:4px;} (A Pandya)

Publication Activity (10 Years)

Top Topics

Top Venues

Ankur Pandya (A Pandya)